Syncom Formulations (India) Ltd
NSE:SYNCOMF
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Telenet Group Holding NV
LSE:0GAF
|
BE |
|
A
|
Advance Synergy Bhd
KLSE:SYNERGY
|
MY |
|
Vivid Global Industries Ltd
BSE:524576
|
IN |
Syncom Formulations (India) Ltd
Total Liabilities
Syncom Formulations (India) Ltd
Total Liabilities Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Total Liabilities | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
S
|
Syncom Formulations (India) Ltd
NSE:SYNCOMF
|
Total Liabilities
₹711.2m
|
CAGR 3-Years
-6%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Dr Reddy's Laboratories Ltd
NSE:DRREDDY
|
Total Liabilities
₹183.6B
|
CAGR 3-Years
30%
|
CAGR 5-Years
16%
|
CAGR 10-Years
N/A
|
|
|
Cipla Ltd
NSE:CIPLA
|
Total Liabilities
₹72.5B
|
CAGR 3-Years
5%
|
CAGR 5-Years
-3%
|
CAGR 10-Years
4%
|
|
|
Sun Pharmaceutical Industries Ltd
NSE:SUNPHARMA
|
Total Liabilities
₹258.9B
|
CAGR 3-Years
7%
|
CAGR 5-Years
3%
|
CAGR 10-Years
1%
|
|
|
Lupin Ltd
NSE:LUPIN
|
Total Liabilities
₹138.7B
|
CAGR 3-Years
12%
|
CAGR 5-Years
7%
|
CAGR 10-Years
11%
|
|
|
T
|
Torrent Pharmaceuticals Ltd
NSE:TORNTPHARM
|
Total Liabilities
₹70.7B
|
CAGR 3-Years
0%
|
CAGR 5-Years
-5%
|
CAGR 10-Years
1%
|
|
Syncom Formulations (India) Ltd
Glance View
Syncom Formulation India Ltd. is a pharmaceutical company, which engages in the development, manufacture, and marketing of healthcare products. The company is headquartered in Indore, Madhya Pradesh. The firm manufactures and markets more than 300 pharmaceutical formulations products in various dosage forms, such as tablets, capsules, liquid orals, liquid vials and ampoule injections and dry vial injections, dry syrups, ointments and inhalers. Its segments include Pharmaceuticals Drugs & Formulations, Trading of Commodities and Renting of property. Its product categories include tablets, capsules, ointments, injections, liquid-oral and packaging variants. The company offers various products, including generics, alpha adrenoceptor agonist, analgesic, antipyretic, anti-inflammatory, anti-ulcer agents, antibiotic, antidepressant, antiviral, cephelo sporins, cortico steroid, estrogen, cough suppressant and sedative anticonvulsant, among others. The firm operates in more than 15 countries across the world.
See Also
What is Syncom Formulations (India) Ltd's Total Liabilities?
Total Liabilities
711.2m
INR
Based on the financial report for Mar 31, 2025, Syncom Formulations (India) Ltd's Total Liabilities amounts to 711.2m INR.
What is Syncom Formulations (India) Ltd's Total Liabilities growth rate?
Total Liabilities CAGR 3Y
-6%
Over the last year, the Total Liabilities growth was -39%. The average annual Total Liabilities growth rates for Syncom Formulations (India) Ltd have been -6% over the past three years .
